Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Oct 21;11(39):6079-84.
doi: 10.3748/wjg.v11.i39.6079.

Research progress of vasculopathy in portal hypertension

Tao Li  1 , Zhen Yang
Affiliations
Review

Research progress of vasculopathy in portal hypertension

Tao Li et al. World J Gastroenterol. .

Abstract

Portal hypertension, one of the vascular diseases, not only has lesions in liver, but also changes in vascular structures and functions of extrahepatic portal system, systemic system and pulmonary circulation. The pathological changes of vasculopathy in portal hypertension include remodeling of arterialized visceral veins, intimal injury of visceral veins and destruction of contractile structure in visceral arterial wall. The mechanisms of vasculopathy in portal hypertension may be attributed to the changes of hemodynamics in portal system, immune response, gene modulation, vasoactive substances, and intrahepatic blood flow resistance. Portal hypertension can cause visceral hyperdynamic circulation, and the development and progression of visceral vasculopathy, while visceral vasculopathy can promote the development and progression of portal hypertension and visceral hyperdynamic circulation in turn. The aforementioned three factors interact in the pathogenesis of hepatic cirrhosis-induced portal hypertension and are involved in hemorrhage due to varicose vein rupture.

PubMed Disclaimer

Figures

Math 1
Math 1
Math(A1).
See this image and copyright information in PMC

References

    1. Yang Z, Liu R, Yang R. Pathology of endothelium, extracellular matrix and smooth muscle in gastric coronary vein of cirrhotic patients. Zhonghua WaiKe ZaZhi. 1996;34:138–140. - PubMed
    1. Lebrec D. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther. 1994;61:65–107. - PubMed
    1. Youssef AI, Escalante-Glorsky S, Bonnet RB, Chen YK. Hemoptysis secondary to bronchial varices associated with alcoholic liver cirrhosis and portal hypertension. Am J Gastroenterol. 1994;89:1562–1563. - PubMed
    1. Burtin P, Calès P, Oberti F, Joundy N, Person B, Carpentier S, Boyer J. Endoscopic ultrasonographic signs of portal hypertension in cirrhosis. Gastrointest Endosc. 1996;44:257–261. - PubMed
    1. Malmqvist U. Effects of long-term portal hypertension on structure, active force and content of contractile and structural proteins in smooth muscle of the rat portal vein. Acta Physiol Scand. 1994;150:171–179. - PubMed

Publication types